<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have studied <z:hpo ids='HP_0011010'>chronic</z:hpo> vasospasm (V.S.) on a primate model (Cynomolgus monkey) </plain></SENT>
<SENT sid="1" pm="."><plain>The conclusion of several studies are: V.S. is related to the presence of adherent clots along cerebral arteries and when severe may lead to <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Clots removal within 48 h. following <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> reduces V.S. intensity </plain></SENT>
<SENT sid="3" pm="."><plain>Free radicals and iron dependent lipidic peroxidation have been involved in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> development </plain></SENT>
<SENT sid="4" pm="."><plain>A new aminosteroid (U 74006 F) can act as a free radical phagocyte and antagonize iron dependent <z:chebi fb="23" ids="18059">lipid</z:chebi> oxidation </plain></SENT>
<SENT sid="5" pm="."><plain>Histological V.S. changes are less important after S.A.H. with 74006F treatment </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="7861">Oxyhemoglobin</z:chebi> high concentration from red blood cells (R.B.C.) <z:mp ids='MP_0010163'>hemolysis</z:mp> has been reported to be responsible for V.S </plain></SENT>
<SENT sid="7" pm="."><plain>Therefore induction of R.B.C. release from the clots before <z:mp ids='MP_0010163'>hemolysis</z:mp> occurs could prevent from high concentration of <z:chebi fb="0" ids="7861">oxyhemoglobin</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>Plasminogen activator can prevent V.S. when used during 72 h. following <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> </plain></SENT>
</text></document>